Noblegen Biosciences Inc is categorized under Analytical Instruments in Concord, MA and active since 2010.
Noblegen Biosciences Inc was established in 2010, and today employs 1 to 4, earning Unknown per year. This is a Analytical Instruments business, which does work in the B2B market, and is classified as a Analytical Instruments, under code number 9999900 by the NAICS.
If you are seeking more information, feel free to contact Philip Buzby, Marketing at the company’s single location by writing to 58 Elsinore St, Concord, Massachusetts MA 01742 or by phoning (978) 405-2533. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Noblegen Biosciences Inc |
| Contact Person: | Philip Buzby, Marketing |
| Address: | 58 Elsinore St, Concord, Massachusetts 01742 |
| Phone Number: | (978) 405-2533 |
| Website Address: | noblegenbio.com |
| Annual Revenue (USD): | Unknown |
| Founded: | 2010 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Analytical Instruments |
| SIC Code: | 3826 |
| NAICS Code: | 9999900 |
| Share This Business: |
Noblegen Biosciences Inc was started in 2010 to provide professional Analytical Instruments under the SIC code 3826 and NAICS code 9999900. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Philip Buzby, Marketing for inquiries that concern Noblegen Biosciences Inc by calling the company number (978) 405-2533, as your correspondence is most welcome. Additionally, the physical location of the single location of Noblegen Biosciences Inc can be found at the coordinates 42.455315,-71.364516 as well as the street address 58 Elsinore St in Concord, Massachusetts 01742.
For its online presence, you may visit Noblegen Biosciences Inc’s website at noblegenbio.com and engage with its social media outlets through on Twitter and on Facebook.